Sponsors evaluate clinical trial sites before study launch to determine whether a site can recruit eligible participants, follow the protocol, protect participants, maintain quality data, and meet operational timelines. The research site feasibility process helps sponsors and CROs gather this information before selecting sites. However, evaluation goes beyond a questionnaire. Sponsors may review the investigator, staff, patient population, facilities, compliance systems, previous performance, and study-specific capabilities before making a decision.

For research sites, understanding this evaluation can make preparation much easier. More importantly, it helps site teams identify weaknesses before those issues affect study startup.

What Do Sponsors Look for in a Clinical Trial Site?

Sponsors generally look for evidence that a site can conduct a specific study safely, efficiently, and according to protocol requirements.

A strong site is not simply one with an experienced investigator or a large patient database. Instead, sponsors may consider how several capabilities work together. Patient access, staffing, facilities, quality systems, regulatory readiness, and communication all contribute to the overall assessment.

However, evaluation criteria can vary by sponsor, therapeutic area, study phase, protocol complexity, and CRO requirements. Therefore, no single checklist applies to every clinical trial.

General Feasibility vs. Study-Specific Site Selection

These two concepts are closely related, but they are not the same.

General site feasibility looks at whether a research site has the basic capabilities needed to conduct clinical research. This can include staffing, facilities, regulatory processes, investigator experience, and general patient access.

Study-specific site selection asks whether that particular site is suitable for one specific protocol.

For example, a site may have extensive experience in clinical research but lack access to the exact patient population required for a new study. Similarly, a site may have strong recruitment capabilities but lack equipment needed for protocol-specific assessments.

In other words, general readiness does not automatically result in study selection.

Which Factors Do Sponsors Evaluate?

Sponsors may examine several areas before deciding whether to activate a site.

Patient Population and Recruitment Potential

Patient access is often a major consideration because enrollment depends on finding eligible participants.

Sponsors may ask about the site's patient population, referral networks, medical records, recruitment methods, and expected enrollment. They may also examine how the site identifies potential participants and whether its estimates are based on realistic sources.

Ask yourself: Can we explain where our study participants will come from?

A broad statement such as “we have many patients” may not provide enough information. Instead, site teams should understand the relevant diagnosis, eligibility criteria, referral patterns, and competing studies.

Principal Investigator Qualifications

The principal investigator's qualifications can provide important context about clinical and research capability.

Sponsors may review education, medical credentials, therapeutic experience, prior trial involvement, training, and availability. Experience with similar protocols or investigational products may also be relevant.

However, experience alone is not enough. The investigator must also have the time and support needed to oversee the study properly.

That matters because even a highly experienced investigator can face challenges when a trial requires frequent participant visits or complex procedures.

Prior Clinical Trial Experience

Sponsors may review a site's previous research activity to understand its operational background.

They may consider:

• Types and phases of previous trials
• Therapeutic areas
• Number of completed studies
• Experience with similar protocols
• Previous sponsor or CRO relationships
• Experience with investigational products
• Experience with electronic study systems

A site with relevant experience can often explain its processes more clearly during feasibility discussions. Meanwhile, newer sites may need to demonstrate readiness through staff qualifications, training, infrastructure, and strong operational planning.

How Does Performance History Affect Site Selection?

Past performance can help sponsors assess whether a site delivers on its commitments.

Depending on the sponsor and study, performance information may include enrollment, retention, protocol deviations, data queries, documentation quality, monitoring findings, and study completion.

For instance, a site that consistently communicates enrollment challenges early gives sponsors useful information for planning. Similarly, accurate and timely documentation can demonstrate that the site understands its research responsibilities.

However, historical performance should always be viewed in context. A site's previous results may not predict performance for a completely different patient population or protocol.

Staff Qualifications and Capacity

The research team supports nearly every part of study execution. Sponsors may therefore review the qualifications, training, experience, and availability of coordinators, nurses, regulatory staff, pharmacists, and other personnel involved in the trial.

Staff capacity also matters.

A site may have qualified employees but limited availability because the team already manages several active studies. As a result, sponsors may want to understand current workload, planned staffing, and how the site will handle additional study responsibilities.

In practice, honest capacity assessments are more useful than optimistic promises.

Facilities and Equipment

Sponsors may assess whether the site has the physical resources required by the protocol.

Depending on the study, this may include:

• Examination and procedure rooms
• Laboratory capabilities
• Refrigerated or controlled storage
• Imaging equipment
• Specialized clinical equipment
• Pharmacy resources
• Secure data systems
• Access to external facilities when needed

Study-specific requirements are especially important here. A site may have excellent general infrastructure but still require additional equipment or vendor arrangements before activation.

Regulatory Readiness and Quality Systems

Regulatory readiness helps demonstrate that a site can manage the required documentation and oversight responsibilities.

Sponsors may review informed consent procedures, training records, delegation logs, essential documents, regulatory submissions, and processes for reporting safety information.

Quality systems may also receive attention. These systems can include standard operating procedures, document control, staff training, corrective and preventive action processes, and internal quality checks.

To be clear, sponsors are not only looking for documents. They may also want evidence that the site's processes work in practice.

Recruitment, Retention, and Enrollment Planning

Recruitment and retention should be treated as separate planning areas.

Recruitment focuses on identifying and enrolling eligible participants. Retention focuses on keeping those participants engaged through required visits and study procedures.

Sponsors may ask how a site plans to address missed visits, participant communication, scheduling problems, transportation barriers, and other practical issues.

What's more, enrollment expectations should be realistic. If a site estimates strong enrollment, it should be able to explain the assumptions behind that estimate.

Communication and Responsiveness

Site communication can affect study startup and ongoing operations.

Sponsors and CROs may evaluate how quickly a site responds to feasibility questions, provides documents, addresses follow-up requests, and communicates potential challenges.

This does not mean every sponsor expects an identical response time. However, consistent and clear communication can help sponsors understand whether a site is prepared to work collaboratively.

From experience, small communication gaps can become larger operational problems when they continue during study startup.

Data Quality and Documentation Practices

Clinical trials depend on reliable data and accurate records. Therefore, sponsors may assess how a site handles source documentation, data entry, queries, corrections, and essential study records.

They may also consider the site's familiarity with systems such as electronic data capture platforms and other sponsor-required technologies.

A site should be able to explain who performs key data tasks, how records are reviewed, and how discrepancies are addressed.

A Step-by-Step Look at Site Evaluation

While approaches vary, a sponsor's evaluation may generally involve the following sequence:

1. Initial site identification

The sponsor or CRO identifies potential sites based on study needs, therapeutic expertise, location, patient access, and other factors.

2. Feasibility assessment

The site provides information about patients, investigator experience, staffing, facilities, recruitment plans, and operational capabilities.

3. Follow-up questions

Sponsors may request clarification or additional documentation when responses require more detail.

4. Site qualification

Depending on the study, the sponsor or CRO may conduct a qualification visit or another detailed assessment.

5. Comparative review

Potential sites may be compared based on their ability to meet protocol requirements, recruitment expectations, timelines, and quality standards.

6. Selection and startup

Selected sites move toward regulatory and contractual activities, training, site initiation, and eventual enrollment.

This process can vary considerably. Some studies may require extensive qualification, while others may use a more streamlined approach.

What Sites Can Do Before Sponsor Evaluation

Preparation should start before a feasibility questionnaire arrives.

Keep investigator CVs, licenses, training records, facility details, equipment information, and regulatory documents current. Also, maintain reliable information about patient populations and referral sources.

Beyond that, track meaningful performance indicators from previous studies. Recruitment, retention, data quality, protocol deviations, and startup timelines can help your team answer sponsor questions with greater confidence.

Finally, identify limitations early. If your site needs additional staff, equipment, training, or recruitment support, knowing this before evaluation gives you time to address the gap.

Conclusion

Sponsors evaluate clinical trial sites by looking at the complete operational picture, not one impressive credential. Patient access, investigator experience, staffing, facilities, regulatory readiness, quality systems, recruitment plans, data practices, communication, and study-specific capabilities can all influence site selection.

Therefore, research sites should prepare with the actual protocol in mind. Strong preparation means knowing what your site can deliver, supporting your answers with accurate information, and being transparent about challenges.

For sites seeking structured support as they build their research capabilities and prepare for future opportunities, CSRS also offers resources for those looking to get enroll clinical research entrepreneur program.